Insulin resistance and subclinical abnormalities of global and regional left ventricular function in patients with aortic valve sclerosis
Conclusions:
Insulin resistance is a powerful independent predictor of subclinical LV dysfunction regardless of concomitant visceral obesity and LV hypertrophy. Thus, it may be a novel therapeutic target to prevent subsequent heart failure in patients with AVS.
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Hiroto UtsunomiyaHideya YamamotoEiji KunitaTakayuki HidakaYasuki Kihara Source Type: research
More News: Calcium | Cardiology | Cardiovascular | Chronic Kidney Disease | CT Scan | Diabetes | Diabetes Mellitus | Eating Disorders & Weight Management | Endocrinology | Heart | Heart Failure | Hypertension | Insulin | Metabolic Syndrome | Obesity | PET Scan | Urology & Nephrology | Women